P. Anticoli Borza

All-oral metronomic DEVEC schedule in elderly patients with peripheral T cell lymphoma

P. Orlandi, G. Bocci, L. Marcheselli, 2020, Cancer Chemotherapy and Pharmacology.

How do patients with aggressive non-Hodgkin's lymphoma treated with third-generation regimens (MACOP-B and F-MACHOP) fare in the long-term?

M. Gobbi, F. Gherlinzoni, F. Mandelli, 1999, Haematologica.

Diffuse large B-cell lymphoma involving the breast. A report of four cases.

M. Marino, F. Pisani, C. Botti, 2006, Journal of experimental & clinical cancer research : CR.

Preliminary results of a counselling programme for fertility preservation in female cancer patients: The experience of the GEMME DORMIENTI network.

S. Hohaus, P. Marchetti, A. Facchiano, 2019, European journal of cancer care.

The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network ‘Rete Ematologica del Lazio per i Linfomi’ (RELLI)

F. D'Alo', S. Hohaus, A. Di Napoli, 2019, Leukemia & lymphoma.